Foghorn Therapeutics (FHTX) Earnings Date, Estimates & Call Transcripts $4.11 -0.22 (-5.08%) As of 05/14/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Foghorn Therapeutics Earnings Summary Foghorn Therapeutics announced Q1 2025 earnings on May 14, 2025, reporting an EPS of -$0.30, which met analysts' consensus estimates of -$0.30. Quarterly revenue was reported to be $5.95 million, above analyst estimates of $4.96 million. With a trailing EPS of -$1.65, Foghorn Therapeutics' earnings are expected to grow next year, from ($1.55) to ($1.02) per share. Latest Q1 Earnings DateMay. 14EstimatedConsensus EPS (May. 14) -$0.30 Actual EPS (May. 14) -$0.30 Actual Revenue (May. 14) $5.95MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get Foghorn Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Foghorn Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataFHTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FHTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Foghorn Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.34-$0.24-$0.30Q2 20253-$0.33-$0.25-$0.30Q3 20253-$0.31-$0.25-$0.29Q4 20253-$0.40-$0.26-$0.32 Foghorn Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025-$0.30-$0.30--$0.30$4.96M$5.95M3/6/2025Q4 2024-$0.43-$0.30+$0.13-$0.30$8.56M$2.86M8/8/2024--$0.60-$0.45+$0.15-$0.45$6.60M$6.89M5/6/2024Q1 2024-$0.55-$0.59 -$0.04-$0.59$7.53M$5.05M3/7/2024Q4 2023-$0.79-$0.57+$0.22-$0.57$4.91M$5.77M11/2/2023Q3 2023-$0.72-$0.34+$0.38-$0.34$6.20M$17.48M8/4/2023Q2 2023-$0.73-$0.70+$0.03-$0.70$6.65M$5.60M Foghorn Therapeutics Earnings - Frequently Asked Questions When did Foghorn Therapeutics announce their last quarterly earnings? Foghorn Therapeutics (NASDAQ:FHTX) last announced its quarterly earning data on Wednesday, May 14, 2025. Learn more on FHTX's earnings history. Did Foghorn Therapeutics beat their earnings estimates last quarter? In the previous quarter, Foghorn Therapeutics (NASDAQ:FHTX) reported ($0.30) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.30). Learn more on analysts' earnings estimate vs. FHTX's actual earnings. How much revenue does Foghorn Therapeutics generate each year? Foghorn Therapeutics (NASDAQ:FHTX) has a recorded annual revenue of $22.60 million. How much profit does Foghorn Therapeutics generate each year? Foghorn Therapeutics (NASDAQ:FHTX) has a recorded net income of -$98.43 million. FHTX has generated -$1.65 earnings per share over the last four quarters. What is Foghorn Therapeutics's EPS forecast for next year? Foghorn Therapeutics's earnings are expected to grow from ($1.55) per share to ($1.02) per share in the next year. More Earnings Resources from MarketBeat Related Companies Mineralys Therapeutics Earnings Collegium Pharmaceutical Earnings Syndax Pharmaceuticals Earnings Arcus Biosciences Earnings Enliven Therapeutics Earnings Avadel Pharmaceuticals Earnings Spyre Therapeutics Earnings Intellia Therapeutics Earnings Pharvaris Earnings Ardelyx Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum HoldsWhy Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery? This page (NASDAQ:FHTX) was last updated on 5/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Foghorn Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Foghorn Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FHTX Stock Free FHTX Stock Alerts